Search for: "Fresenius USA Marketing, Inc." Results 1 - 15 of 15
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2015, 4:42 am by Rebecca Tushnet
Fresenius Kabi USA LLC, 2015 WL 1263041, No. 14 C 3349 (N.D. [read post]
8 May 2019, 7:14 am by Rebecca Tushnet
Fresenius Kabi USA LLC, No. 14-cv-3349, 2015 WL 1263041, at *4 (N.D. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
How much the product is used or unused in the market. [read post]
11 Jun 2008, 2:19 pm
Air Climate Systems, Inc. and All Climate Systems, Inc. (30-CA-17695; 352 NLRB No. 75) Janesville, WI May 30, 2008. [read post]
5 Nov 2010, 1:38 pm
On appeal, defendant's objected to Finjan's applying the entire market value rule for royalty base. [read post]
14 Sep 2009, 5:51 am
– America-Israel Patent Law) Accelerated examination (Inventive Step) Suggestions for USPTO Director David Kappos (IP Watchdog) Mystery graph of the day (Patently-O) The crisis in the American patent system (CanadaPatentBlog)   US Patents – Decisions CAFC debates stays pending re-examination; Injunctions when claims are of ‘suspect validity’: Fresenius USA, Inc v Baxter International, Inc (Patently-O) (IP Law… [read post]
1 Nov 2008, 3:12 am
(Ars Technica) CAFC: Co-inventors contribution must be 'more than the exercise of ordinary skill'; NTP awarded attorneys' fees: Oren Tavory v NTP (Patently-O) (Law360) (Law360) (Property, intangible) (Patent Prospector) (Property, intangible) PTO announces no IDS or Markush Rules during Bush Administration (Patent Prospector) (Hal Wegner) (Patently-O) (Patent Docs)   Global Global - General Exploding the intangible asset market cap myth (IP Think Tank) In-depth… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma… [read post]
11 Apr 2008, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC overturns final judgment in Google’s favour in case brought by Leo Stoller who seeks to have Google’s trade mark declared generic: (IP Law360), (Trademark Blog), European Parliament says ‘no’ to disconnecting P2P users: (Ars Technica), (Techdirt), (Intellectual Property Watch), (Electronic… [read post]